PTH

Invesco DWA Healthcare Momentum ETF

Down$79.99
$-0.13
(-0.16%)
As of 12:00:00 AM EDT | 10/18/19  |  Market Closed

PTH Trading Data

Open

$79.6

Low Price

$79.31

High Price

$80.22

Previous Last Price

$80.13

Bid Size

$0 X 0

Ask Size

$0 X 0

PTH Portfolio Data

AUM

$120,135,000

Shares

1,500

PE Ratio

495.74

Price / Book Ratio

6.52

Expense Ratio

0.6

Net Asset Value

$80.09

Volume

Volume

5,500

Avg. Volume (YDT)

14,904

Dollar Volume

$0

Weekly Avg. Volume

7,700

Monthly Avg. Volume

6,935

Quarterly Avg. Volume

8,314

PTH Fund Description

The Invesco DWA Healthcare Momentum ETF is based on the Dorsey Wright Healthcare Technical Leaders Index (DWA Healthcare Technical Leaders Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to identify companies that are showing relative strength (momentum), and is composed of at least 30 common stocks from the NASDAQ US Benchmark Index. The Fund and the Index are rebalanced and reconstituted quarterly.

PTH Chart

PTH Summary

Fund Family

Invesco

Tracks This Index

Invesco DWA Healthcare Momentum ETF

Inception Date

2010-12-06

Asset Class

Equity

Asset Class Size

Biotech

PTH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

PTH Holdings

Top 10 Holdings

Exact Sciences Corp (EXAS)
5.65%
Masimo Corp (MASI)
4.49%
Thermo Fisher Scientific Inc (TMO)
4.28%
Insulet Corp (PODD)
4.21%
Edwards Lifesciences Corp (EW)
3.98%
Becton Dickinson and Co (BDX)
3.52%
IDEXX Laboratories Inc (IDXX)
3.43%
Humana Inc (HUM)
3.27%
DexCom Inc (DXCM)
3.17%
Boston Scientific Corp (BSX)
3.05%

Total PTH Holdings

Total Holdings: 46

Exact Sciences Corp (EXAS)
5.65%
Masimo Corp (MASI)
4.49%
Thermo Fisher Scientific Inc (TMO)
4.28%
Insulet Corp (PODD)
4.21%
Edwards Lifesciences Corp (EW)
3.98%
Becton Dickinson and Co (BDX)
3.52%
IDEXX Laboratories Inc (IDXX)
3.43%
Humana Inc (HUM)
3.27%
DexCom Inc (DXCM)
3.17%
Boston Scientific Corp (BSX)
3.05%
ACADIA Pharmaceuticals Inc (ACAD)
3.04%
Medicines Co/The (MDCO)
2.98%
Repligen Corp (RGEN)
2.85%
Zoetis Inc (ZTS)
2.82%
Intuitive Surgical Inc (ISRG)
2.73%
West Pharmaceutical Services Inc (WST)
2.35%
Tandem Diabetes Care Inc (TNDM)
2.34%
Allakos Inc (ALLK)
2.33%
ResMed Inc (RMD)
2.18%
Neurocrine Biosciences Inc (NBIX)
2.18%
Cardiovascular Systems Inc (CSII)
2.13%
Natera Inc (NTRA)
2.13%
Axsome Therapeutics Inc (AXSM)
1.98%
LHC Group Inc (LHCG)
1.95%
Haemonetics Corp (HAE)
1.89%
HMS Holdings Corp (HMSY)
1.71%
Integer Holdings Corp (ITGR)
1.67%
Dova Pharmaceuticals Inc (DOVA)
1.62%
Arrowhead Pharmaceuticals Inc (ARWR)
1.61%
Hill-Rom Holdings Inc (HRC)
1.58%
Medpace Holdings Inc (MEDP)
1.54%
Karyopharm Therapeutics Inc (KPTI)
1.47%
Lannett Co Inc (LCI)
1.32%
Nevro Corp (NVRO)
1.25%
Coherus Biosciences Inc (CHRS)
1.24%
Inspire Medical Systems Inc (INSP)
1.22%
Biohaven Pharmaceutical Holding Co Ltd (BHVN)
1.17%
CONMED Corp (CNMD)
1.14%
Hanger Inc (HNGR)
1.05%
US Physical Therapy Inc (USPH)
1.01%
CEL-SCI Corp (CVM)
1%
G1 Therapeutics Inc (GTHX)
0.9%
Addus HomeCare Corp (ADUS)
0.86%
Catalyst Pharmaceuticals Inc (CPRX)
0.85%
Krystal Biotech Inc (KRYS)
0.84%
PowerShares DWA Healthcare Momentum Portfolio ETF (PTH)
0%

PTH Technicals

Alpha

9.31

Beta

1.39

Leverage

Long

Standard Deviation

6.04

PTH Dividends

Dividend Date

2013-12-20

Latest Dividend

0.0341

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

PTH Performance

YTD Return

12.38%

1 Year Return

-8.13%

3 Year Return

64.08%

5 Year Return

54.48%

10 Year Return

283.28%

PTH Related Articles

Two Big Factors Hurting Biotech ETFs

Two Big Factors Hurting Biotech ETFs

Exorbitant drug price concerns and a new Trans-Pacific Partnership deal sent biotech stocks and sector exchange traded funds reeling Tuesday.…

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.